Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Launch date
Employees
Market cap
$9.6b
Enterprise valuation
$9.3b (Public information from Sep 2024)
Share price
€111.9 IPN.PA
Boulogne-Billancourt Île-de-France (HQ)
No columns specified